Loading clinical trials...
Loading clinical trials...
Andrographolides With or Without Capecitabine for Elderly Patients With Locally Advanced or Recurrent or Metastasis Inoperable Colorectal Cancer: a Randomized, Open-label Trial.
Conditions
Interventions
Andrographolides
Capecitabine
Locations
1
China
the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Start Date
November 1, 2013
Primary Completion Date
December 1, 2016
Completion Date
December 1, 2016
Last Updated
January 14, 2020
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
Gu Yanhong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions